Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Market for Post Menopausal Vaginal Atrophy Drugs – What’s hot, what’s not, what’s next by 2021?

Tuesday, January 10, 2017 4:58
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Post Menopausal Vaginal Atrophy Drugs Market Research Report covers the present scenario and the growth prospects of the Post Menopausal Vaginal Atrophy Drugs Industry for 2016-2020. Post Menopausal Vaginal Atrophy Drugs Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years and discussion of the key vendors effective in this market. To calculate the market size, the report considers the revenue generated from the sales of Post Menopausal Vaginal Atrophy Drugs globally.

For further information on this report, please visit- http://www.marketreportsworld.com/10278694

The Post Menopausal Vaginal Atrophy Drugs Market report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.

 
Following Companies Are Key Players of the Post Menopausal Vaginal Atrophy Drugs Market:

  • Pfizer Inc.
  • Allergan Inc.
  • Shionogi & Co. Ltd.
  • Novo Nordisk A/S
  • Teva Pharmaceutical Industries Ltd.

Other Prominent Vendors of Post Menopausal Vaginal Atrophy Drugs Market Are:

  • Bayer
  • Bionovo
  • EndoCeutics
  • Foamix Pharmaceuticals
  • Ligand Pharmaceuticals
  • Pantarhei Bioscience

“Non-estrogenic therapies in PVA treatment are a paradigm shift from systemic estrogen therapies such as creams, patches, and gels. In addition, the launch of late-stage pipeline products is expected to shift the attention from vaginal creams and OTC classes toward vaginal tablets and oral therapies. For instance, the recent launch of two non-estrogenic therapies with improved safety profiles, Osphena by Shionogi and BZA/CE by Bayer, will allow manufacturers to tap a large pool of untreated people.  ”

Ask Sample PDF of Post Menopausal Vaginal Atrophy Drugs Market Report @ http://www.marketreportsworld.com/enquiry/request-sample/10278694  

According to the Post Menopausal Vaginal Atrophy Drugs Market report, the Affordable Care Act has increased the number of insured women and has been a driving factor in the treatment-seeking behavior of people with this condition. The law puts in place comprehensive health insurance reforms that will roll out over four years and beyond. This provides Americans with better health security by putting in place comprehensive health insurance reforms that lower healthcare costs and expand the coverage.
 

Report also presents Geographical Segmentation analysis of Post Menopausal Vaginal Atrophy Drugs Market of Americas, APAC, EMEA region.

 

For Any Query, Contact Our Expert @ http://www.marketreportsworld.com/enquiry/pre-order-enquiry/10278694

Further, the Post Menopausal Vaginal Atrophy Drugs Market report states that the market is currently served by generic products due to the patent expiries of branded products such as Premarin, which lost its patent in 2012. The patent of Colpotrophine also expired in 2015. Patent expiries will lead to the entry of generic versions of the particular drugs in the market, resulting in the sales erosion of branded products. This will result in heavy financial loss to the parent drug makers.

Key questions answered in Post Menopausal Vaginal Atrophy Drugs market report:

  • What will the Post Menopausal Vaginal Atrophy Drugs market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving Post Menopausal Vaginal Atrophy Drugs market?
  • What are the challenges to Post Menopausal Vaginal Atrophy Drugs market growth?
  • Who are the key vendors in Post Menopausal Vaginal Atrophy Drugs market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

 

No of Pages: 69

Price of Report: $ 2500 (Single User License)

Purchase Report @ http://www.marketreportsworld.com/purchase/10278694

About Market Reports World:

Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.

Contact–

Mr. Ameya Pingaley

Market Reports World

+1 408 520 9750

Email – sales@marketreportsworld.com

http://www.marketreportsworld.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.